BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

976 related articles for article (PubMed ID: 18705832)

  • 1. Case of linear immunoglobulin A bullous dermatosis associated with acquired hemophilia.
    Arakaki O; Yamamoto Y; Awazawa R; Nonaka K; Taira K; Asato Y; Hagiwara K; Oyama B; Ishii N; Hashimoto T; Uezato H
    J Dermatol; 2008 Jul; 35(7):437-46. PubMed ID: 18705832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case of mixed bullous disease of epidermolysis bullosa acquisita and linear IgA bullous dermatosis.
    Osawa M; Demitsu T; Toda S; Yokokura H; Umemoto N; Yamada T; Yoneda K; Kakurai M; Yoshida M; Hashimoto T
    Dermatology; 2005; 211(2):146-8. PubMed ID: 16088162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Linear immunoglobulin A/immunoglobulin G bullous dermatosis associated with Vogt-Koyanagi-Harada disease.
    Yanagihara S; Mizuno N; Naruse A; Tateishi C; Tsuruta D; Ishii M
    J Dermatol; 2011 Aug; 38(8):798-801. PubMed ID: 21545501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Drug induced linear IgA bullous dermatosis].
    Montagnac R; Reguiaï Z; Méhaut S; Bressieux JM; Schillinger F
    Nephrologie; 2003; 24(6):287-92. PubMed ID: 14584295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Linear immunoglobulin A bullous dermatosis.
    Fortuna G; Marinkovich MP
    Clin Dermatol; 2012; 30(1):38-50. PubMed ID: 22137225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence and distribution of subepidermal autoimmune bullous skin diseases in three French regions. Bullous Diseases French Study Group.
    Bernard P; Vaillant L; Labeille B; Bedane C; Arbeille B; Denoeux JP; Lorette G; Bonnetblanc JM; Prost C
    Arch Dermatol; 1995 Jan; 131(1):48-52. PubMed ID: 7826096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A subepidermal blistering dermatosis associated with coexistent IgG and IgA anti-dermal basement membrane zone antibodies; demonstration of IgG antibodies reactive against a 200-kDa dermal antigen.
    Watanabe M; Tsunoda T; Tagami H
    Eur J Dermatol; 2002; 12(6):603-6. PubMed ID: 12459541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Linear IgA bullous dermatosis in a child].
    Miklaszewska M; Dabrowska-Widera J
    Przegl Dermatol; 1982; 69(4):287-90. PubMed ID: 6764008
    [No Abstract]   [Full Text] [Related]  

  • 9. [Linear IgA bullous dermatosis: the importance of a correct differential diagnosis].
    Colombo M; Volpini S; Orini S; Fazi MC; Vettore E; Tedoldi S; Cappellaro E
    Minerva Pediatr; 2008 Jun; 60(3):351-3. PubMed ID: 18487982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A morbilliform variant of vancomycin-induced linear IgA bullous dermatosis.
    Billet SE; Kortuem KR; Gibson LE; El-Azhary R
    Arch Dermatol; 2008 Jun; 144(6):774-8. PubMed ID: 18559768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-induced linear IgA bullous dermatosis.
    Navi D; Michael DJ; Fazel N
    Dermatol Online J; 2006 Sep; 12(5):12. PubMed ID: 16962027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Linear IgA bullous dermatosis induced by atorvastatin.
    König C; Eickert A; Scharfetter-Kochanek K; Krieg T; Hunzelmann N
    J Am Acad Dermatol; 2001 Apr; 44(4):689-92. PubMed ID: 11260550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of linear IgA bullous dermatosis of childhood with flucloxacillin.
    Alajlan A; Al-Khawajah M; Al-Sheikh O; Al-Saif F; Al-Rasheed S; Al-Hoqail I; Hamadah IR
    J Am Acad Dermatol; 2006 Apr; 54(4):652-6. PubMed ID: 16546588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Verapamil-induced linear IgA disease mimicking toxic epidermal necrolysis].
    Schroeder D; Saada D; Rafaa M; Ingen-Housz-Oro S; Valeyrie-Allanore L; Sigal ML
    Ann Dermatol Venereol; 2011; 138(4):302-6. PubMed ID: 21497257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Linear IgA bullous dermatosis following influenza vaccination.
    Alberta-Wszolek L; Mousette AM; Mahalingam M; Levin NA
    Dermatol Online J; 2009 Nov; 15(11):3. PubMed ID: 19951639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vancomycin-induced linear IgA bullous disease presenting as toxic epidermal necrolysis.
    Waldman MA; Black DR; Callen JP
    Clin Exp Dermatol; 2004 Nov; 29(6):633-6. PubMed ID: 15550142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoimmune blistering dermatoses as systemic diseases.
    Vassileva S; Drenovska K; Manuelyan K
    Clin Dermatol; 2014; 32(3):364-75. PubMed ID: 24767184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoimmune responses in patients with linear IgA bullous dermatosis: both autoantibodies and T lymphocytes recognize the NC16A domain of the BP180 molecule.
    Lin MS; Fu CL; Olague-Marchan M; Hacker MK; Zillikens D; Giudice GJ; Fairley JA
    Clin Immunol; 2002 Mar; 102(3):310-9. PubMed ID: 11890718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoimmune bullous skin diseases. Part 1: Clinical manifestations.
    Kneisel A; Hertl M
    J Dtsch Dermatol Ges; 2011 Oct; 9(10):844-56; quiz 857. PubMed ID: 21955378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Linear IgA bullous dermatosis (author's transl)].
    Chorzelski T; Jabłońska S; Maciejowska E
    Przegl Dermatol; 1980; 67(5):533-9. PubMed ID: 7005969
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 49.